Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer Meeting Abstract
| Authors: | Shah, M. H.; Sherman, E. J.; Robinson, B.; Solomon, B. J.; Kang, H.; Lorch, J. H.; Worden, F. P.; Brose, M. S.; Leboulleux, S.; Godbert, Y.; Meurer, M.; Morris, J. C.; Owonikoko, T. K.; Tan, D. S. W.; Gautschi, O.; Patel, J. D.; Yang, L. X.; Kherani, J.; Cabanillas, M. E.; Wirth, L. J. |
| Abstract Title: | Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368301485 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.3594 |
| Notes: | Meeting Abstract: 3594 -- Source: Wos |
